Analysis of p53-RNA interactions in cultured human cells

Biochemical and Biophysical Research Communications

Volumn 363, Issue 2, 2007, Pages 381-387

  Riley, Kasandra J L ^a   James Maher III, L ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

CLIP; Formaldehyde; p53; RNA; UV cross linking

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PROTEIN P53; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; NULL CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PURIFICATION; PROTEIN RNA BINDING;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; PROTEIN BINDING; RNA; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34748915767     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.181     Document Type: Article

References (31)

1. Laptenko O., and Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 13 (2006) 951-961
2. Lavin M.F., and Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 13 (2006) 941-950
3. Baroni T.E., Wang T., Qian H., Dearth L.R., Truong L.N., Zeng J., Denes A.E., Chen S.W., and Brachmann R.K. A global suppressor motif for p53 cancer mutants. Proc. Natl. Acad. Sci. USA 101 (2004) 4930-4935
4. J.-K. Riley, L.J. Maher, 3rd, p53-RNA interactions: new clues in an old mystery, RNA, in press. Available online 5 September 2007. PMID: 17804642.
5. Hall K.B. RNA-protein interactions. Curr. Opin. Struct. Biol. 12 (2002) 283-288
6. Riley K.J., Cassiday L.A., Kumar A., and Maher III L.J. Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system. RNA 12 (2006) 620-630
7. Riley K.J., Ramirez-Alvarado M., and Maher III L.J. RNA-p53 interactions in vitro. Biochemistry 46 (2007) 2480-2487
8. Friedler A., Veprintsev D.B., Freund S.M., von Glos K.I., and Fersht A.R. Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure (Camb.) 13 (2005) 629-636
9. Nedbal W., Frey M., Willemann B., Zentgraf H., and Sczakiel G. Mechanistic insights into p53-promoted RNA-RNA annealing. J. Mol. Biol. 266 (1997) 677-687
10. Levin J.G., Guo J., Rouzina I., and Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 80 (2005) 217-286
11. Ivanyi-Nagy R., Davidovic L., Khandjian E.W., and Darlix J.L. Disordered RNA chaperone proteins: from functions to disease. Cell Mol. Life Sci. 62 (2005) 1409-1417
12. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15 (2005) 35-41
13. Oberosler P., Hloch P., Ramsperger U., and Stahl H. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12 (1993) 2389-2396
14. Fontoura B.M., Sorokina E.A., David E., and Carroll R.B. p53 is covalently linked to 5.8S rRNA. Mol. Cell. Biol. 12 (1992) 5145-5151
15. Samad A., and Carroll R.B. The tumor suppressor p53 is bound to RNA by a stable covalent linkage. Mol. Cell Biol. 11 (1991) 1598-1606
16. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., and Deppert W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14 (1995) 4442-4449
17. Miller S.J., Suthiphongchai T., Zambetti G.P., and Ewen M.E. p53 binds selectively to the 5′ untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4. Mol. Cell Biol. 20 (2000) 8420-8431
18. Galy B., Creancier L., Prado-Lourenco L., Prats A.C., and Prats H. p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20 (2001) 4613-4620
19. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Yoshida T., Itoh H., and Kohno K. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity. Oncogene 23 (2004) 4371-4379
20. Mili S., and Steitz J.A. Evidence for reassociation of RNA-binding proteins after cell lysis: implications for the interpretation of immunoprecipitation analyses. Rna 10 (2004) 1692-1694
21. Niranjanakumari S., Lasda E., Brazas R., and Garcia-Blanco M.A. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26 (2002) 182-190
22. Ule J., Jensen K., Mele A., and Darnell R.B. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods 37 (2005) 376-386
23. Bunz F., Hwang P.M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K.W., and Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104 (1999) 263-269
24. Ou Y.H., Chung P.H., Sun T.P., and Shieh S.Y. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol. Biol. Cell 16 (2005) 1684-1695
25. Bergamaschi D., Samuels Y., O'Neil N.J., Trigiante G., Crook T., Hsieh J.K., O'Connor D.J., Zhong S., Campargue I., Tomlinson M.L., Kuwabara P.E., and Lu X. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat. Genet. 33 (2003) 162-167
26. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., Fotouhi N., and Liu E.A. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
27. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Itoh H., Kang D., and Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res. 63 (2003) 3729-3734
28. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
29. Rohaly G., Chemnitz J., Dehde S., Nunez A.M., Heukeshoven J., Deppert W., and Dornreiter I. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122 (2005) 21-32
30. Harms K.L., and Chen X. The C terminus of p53 family proteins is a cell fate determinant. Mol. Cell Biol. 25 (2005) 2014-2030
31. Ule J., Jensen K.B., Ruggiu M., Mele A., Ule A., and Darnell R.B. CLIP identifies Nova-regulated RNA networks in the brain. Science 302 (2003) 1212-1215